Kestra Medical Technologies (KMTS) Revenue (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Revenue data on file, last reported at $24.6 million in Q1 2026.

• Revenue for Q1 2026 came in at $24.6 million, up 62.7% year-over-year; the trailing twelve-month figure through Jan 2026 was $83.7 million (up 59.06% YoY), and the FY2025 annual result was $59.8 million, up 115.05% from the prior year.
• Revenue improved to $24.6 million in Q1 2026 per KMTS's latest filing, from $22.6 million in the prior quarter.
• Over five years, Revenue peaked at $24.6 million in Q1 2026 and troughed at $8.3 million in Q1 2024.
• A 3-year average of $16.1 million and a median of $15.1 million in 2025 frame the typical range for Revenue.
• On a YoY basis, Revenue climbed as much as 82.31% in 2025 and fell as far as 51.55% in 2025.
• A 3-year view of Revenue shows it stood at $14.7 million in 2024, then surged by 53.4% to $22.6 million in 2025, then rose by 8.81% to $24.6 million in 2026.
• Business Quant data shows KMTS's Revenue at $24.6 million in Q1 2026, $22.6 million in Q4 2025, and $19.4 million in Q3 2025.